JPH01113315A - ビタミンk↓2含有脂肪乳剤 - Google Patents
ビタミンk↓2含有脂肪乳剤Info
- Publication number
- JPH01113315A JPH01113315A JP26663287A JP26663287A JPH01113315A JP H01113315 A JPH01113315 A JP H01113315A JP 26663287 A JP26663287 A JP 26663287A JP 26663287 A JP26663287 A JP 26663287A JP H01113315 A JPH01113315 A JP H01113315A
- Authority
- JP
- Japan
- Prior art keywords
- fat emulsion
- vitamin
- fat
- emulsion
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26663287A JPH01113315A (ja) | 1987-10-23 | 1987-10-23 | ビタミンk↓2含有脂肪乳剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26663287A JPH01113315A (ja) | 1987-10-23 | 1987-10-23 | ビタミンk↓2含有脂肪乳剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01113315A true JPH01113315A (ja) | 1989-05-02 |
JPH0422886B2 JPH0422886B2 (enrdf_load_stackoverflow) | 1992-04-20 |
Family
ID=17433524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP26663287A Granted JPH01113315A (ja) | 1987-10-23 | 1987-10-23 | ビタミンk↓2含有脂肪乳剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01113315A (enrdf_load_stackoverflow) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6007826A (en) * | 1992-03-16 | 1999-12-28 | Yisum Research Development Company Of The Hebrew University Of Jerusalem | Oil-in-water emulsions of positively charged particles |
WO2011153513A3 (en) * | 2010-06-03 | 2012-04-26 | Latitude Pharma | Nanoemulsion composition containing vitamin k |
JP2017533183A (ja) * | 2014-09-19 | 2017-11-09 | ヘロン セラピューティクス, インコーポレイテッド | アプレピタントのエマルジョン製剤 |
US11173118B2 (en) | 2016-02-01 | 2021-11-16 | Heron Therapeutics, Inc. | Emulsion formulations of an NK-1 receptor antagonist and uses thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5665817A (en) * | 1979-10-31 | 1981-06-03 | Teikoku Chem Ind Corp Ltd | Vitamin k injection |
JPS57209216A (en) * | 1981-06-19 | 1982-12-22 | Daigo Eiyou Kagaku Kk | Compound fat-soluble vitamin injection capable of being medicated by venoclysis and its preparation |
JPS58162517A (ja) * | 1982-03-19 | 1983-09-27 | Green Cross Corp:The | 脂溶性ビタミン含有脂肪乳剤 |
-
1987
- 1987-10-23 JP JP26663287A patent/JPH01113315A/ja active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5665817A (en) * | 1979-10-31 | 1981-06-03 | Teikoku Chem Ind Corp Ltd | Vitamin k injection |
JPS57209216A (en) * | 1981-06-19 | 1982-12-22 | Daigo Eiyou Kagaku Kk | Compound fat-soluble vitamin injection capable of being medicated by venoclysis and its preparation |
JPS58162517A (ja) * | 1982-03-19 | 1983-09-27 | Green Cross Corp:The | 脂溶性ビタミン含有脂肪乳剤 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6007826A (en) * | 1992-03-16 | 1999-12-28 | Yisum Research Development Company Of The Hebrew University Of Jerusalem | Oil-in-water emulsions of positively charged particles |
WO2011153513A3 (en) * | 2010-06-03 | 2012-04-26 | Latitude Pharma | Nanoemulsion composition containing vitamin k |
US9370486B2 (en) | 2010-06-03 | 2016-06-21 | Latitude Pharmaceuticals Inc. | Nanoemulsion composition containing vitamin K |
JP2017533183A (ja) * | 2014-09-19 | 2017-11-09 | ヘロン セラピューティクス, インコーポレイテッド | アプレピタントのエマルジョン製剤 |
JP2019196398A (ja) * | 2014-09-19 | 2019-11-14 | ヘロン セラピューティクス, インコーポレイテッド | アプレピタントのエマルジョン製剤 |
US10953018B2 (en) | 2014-09-19 | 2021-03-23 | Heron Therapeutics, Inc. | Emulsion formulations of aprepitant |
US12290520B2 (en) | 2014-09-19 | 2025-05-06 | Heron Therapeutics, Inc. | Methods of use of emulsion formulations of aprepitant |
US11173118B2 (en) | 2016-02-01 | 2021-11-16 | Heron Therapeutics, Inc. | Emulsion formulations of an NK-1 receptor antagonist and uses thereof |
US12115254B2 (en) | 2016-02-01 | 2024-10-15 | Heron Therapeutics, Inc. | Methods of use of emulsion formulations of an NK-1 receptor antagonist |
US12115255B2 (en) | 2016-02-01 | 2024-10-15 | Heron Therapeutics, Inc. | Methods of use of emulsion formulations of an NK-1 receptor antagonist |
Also Published As
Publication number | Publication date |
---|---|
JPH0422886B2 (enrdf_load_stackoverflow) | 1992-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4212113B2 (ja) | サイクロスポリン乳剤 | |
Collins-Gold et al. | Parenteral emulsions for drug delivery | |
KR101391020B1 (ko) | 수난용성 약제를 함유한 약학 조성물 | |
JPS6144809A (ja) | 4−ビフエニリル酢酸系化合物含有脂肪乳剤 | |
NO844144L (no) | Legemiddeltilberedning | |
JP2018514505A (ja) | 非経口投与用のエマルション | |
KR20010051463A (ko) | 오일 면역 보강제 백신 | |
JP2688235B2 (ja) | 医薬物質含有脂肪乳剤の用時調製型キットおよび医薬物質含有脂肪乳剤の調製方法 | |
KR20170071467A (ko) | 동결 융해를 견딜 수 있는 지방 유제에 고농도 글리세린의 응용 | |
EP0799035B1 (en) | Emulsion suitable for administering a sphingolipid and use thereof | |
KR20220152228A (ko) | 포스파티딜콜린을 함유하는 해바라기 인지질 조성물 | |
JP2005225818A (ja) | パクリタキセル又はドセタキセルの医薬組成物 | |
JP2543708B2 (ja) | 難溶性薬物を封入したエマルジョン製剤の製造方法 | |
JP3132085B2 (ja) | 脂肪乳剤 | |
JPH0145446B2 (enrdf_load_stackoverflow) | ||
JPH01113315A (ja) | ビタミンk↓2含有脂肪乳剤 | |
Rosoff | Specialized pharmaceutical emulsions | |
Gupta et al. | for Drug Solubilization and Delivery | |
JP4719355B2 (ja) | パルトリシン誘導体の注射可能な薬学的処方物 | |
EP3316859B1 (en) | Propofol emulsion for parenteral administration | |
JP2002241284A (ja) | 全身投与用アルガトロバン注射液 | |
WO1991007964A1 (en) | Fat emulsion | |
Cannon et al. | 10 Emulsions, Microemulsions, and Lipid-Based Drug | |
JPH0672890A (ja) | オーレオバシジン類の乳化製剤 | |
Cannon et al. | 211 Emulsions, Microemulsions, and Lipid-Based Drug Delivery Systems for Drug Solubilization and Delivery—Part I: Parenteral Applications |